MP43: Prostate Cancer: Localized: Active Surveillance

Sunday, May 15, 2022

10:30 AM – 11:45 AM

Location: Room 222

Poster Session Moderator(s)

Joseph Smith, Jr, MD

Vanderbilt University
Peter Carroll, MD, MPH (he/him/his)

Professor
University Of California, San Francisco
SH

Sung Kyu Hong, MD (he/him/his)

Professor
Seoul National University College of Medicine

Presentations:

10:30 AM – 11:45 AM

MP43-01: Clinical Significance of Detection of Perineural Invasion in Low-risk men on Active Surveillance
Poster Presenter: Claire M. De La Calle, MD – Johns Hopkins Univeristy
10:30 AM – 11:45 AM

MP43-02: Preference elicitation and treatment decision making among men diagnosed with localized prostate cancer: Results from the Healium Trial.
Poster Presenter: Michael A. Diefenbach, PHD
10:30 AM – 11:45 AM

MP43-03: Active surveillance for low-risk prostate cancer: time trends and variation in the AUA Quality (AQUA) Registry
Poster Presenter: Matthew Randal Cooperberg, MD
10:30 AM – 11:45 AM

MP43-04: Comparison of 4K score, Prostate Health Index, and PSA density in Active Surveillance
Poster Presenter: Bruce J. Trock, PhD
10:30 AM – 11:45 AM

MP43-05: Upfront MRI is the new standard, have confirmatory biopsies become obsolete?
Poster Presenter: Ivo De Vos, MD,MSc
10:30 AM – 11:45 AM

MP43-06: Comparing MRI/US Fusion to Standard Prostate Biopsy in Determining Grade Reclassification at Confirmatory Biopsy in a Multi-Institutional Active Surveillance Cohort: A Pennsylvania Urology Regional Collaborative (PURC) Analysis
Poster Presenter: David M. Strauss, MD
10:30 AM – 11:45 AM

MP43-07: Negative Prostate MRI as a Predictor of Disease Stability in Patients on Active Surveillance
Poster Presenter: Jacob Enders, BS
10:30 AM – 11:45 AM

MP43-08: Active Surveillance for prostate cancer: uptake over time and the impact of an organized protocol
Poster Presenter: Sebastiaan Remmers, MSC – Erasmus MC
10:30 AM – 11:45 AM

MP43-09: Risk of Adverse Pathology after Deferred Prostatectomy for Grade Group 1 and 2 Prostate Cancer Being Managed by Active Surveillance
Poster Presenter: Cheyenne Williams, MD
10:30 AM – 11:45 AM

MP43-10: Impact of family history and germline genetic risk variants on long-term outcomes of active surveillance-eligible prostate cancer
Poster Presenter: Keyan Salari
10:30 AM – 11:45 AM

MP43-11: The Use and Outcomes of Men with NCCN Favorable Intermediate Risk Prostate Cancer Managed with Active Surveillance
Poster Presenter: Roshan Paudel – University of Michigan
10:30 AM – 11:45 AM

MP43-12: Impact of NCCN-Compliant Multidisciplinary Conference on the Utilization of Active Surveillance for Patients with Localized Prostate Cancer
Poster Presenter: Yousuf Omar Ramahi, BS
10:30 AM – 11:45 AM

MP43-13: Interlaboratory Gleason Grading Variation Affects Treatment: a Dutch Historic Cohort Study in 30,509 Prostate Cancer Patients
Poster Presenter: Rachel Flach – UMC Utrecht
10:30 AM – 11:45 AM

MP43-14: External validation of a model predicting increase in Gleason grade for men on Active Surveillance in the GAP3 consortium database
Poster Presenter: Daan Nieboer – Erasmus MC
10:30 AM – 11:45 AM

MP43-15: A 5-year Prospective Study of African American Men on Prostate Cancer Active Surveillance: Does Race Predict Upgrading?
Poster Presenter: Joshua Pincus
10:30 AM – 11:45 AM

MP43-16: Racial Disparities in Rates of Gleason Grade Reclassification in a Multi-Institutional Prostate Cancer Active Surveillance Cohort: A Pennsylvania Urology Regional Collaborative (PURC) Analysis
Poster Presenter: Rohit Reddy, MD, BA – Temple University Hospital
10:30 AM – 11:45 AM

MP43-17: Predicting True Pathologic Gleason Grade During Active Surveillance for Prostate Cancer: Calibration of the Johns Hopkins ActiveCare Model in Five Large Active Surveillance Cohorts
Poster Presenter: Christian Paul Pavlovich, MD – Johns Hopkins Hospital
10:30 AM – 11:45 AM

MP43-18: Prostate Cancer Mortality Rates in Low and Favorable Intermediate Risk Active Surveillance Patients: A Population-Based Competing Risks Analysis
Poster Presenter: Rashid Sayyid, MD
10:30 AM – 11:45 AM

MP43-19: Drop-out Rates from Active Surveillance for Disease Progression Remain Consistent and Not Negligible Over Time. A Plea for Long-term Assessment Based on a Large, Prospectively Collected Active Surveillance Cohort
Poster Presenter: Luigi Nocera – IRCCS Ospedale San Raffaele
10:30 AM – 11:45 AM

MP43-20: Long Term Health-Related Quality Of Life (HRQoL) Outcomes After Surgery, Radiotherapy, or Active Surveillance For Localized Prostate Cancer
Poster Presenter: Eyal Kord, MD,MPH